Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+0,47%
1 067,36
+4,96
+0,47%
—1 062,401 064,141 071,991 061,02——
SIXC
Communications
SIXC
Communications
SIXC
-0,54%
603,48
-3,26
-0,54%
—606,74606,74609,84602,33——
SIXE
Energy
SIXE
Energy
SIXE
+0,54%
1 244,93
+6,72
+0,54%
—1 238,211 236,601 247,741 232,10——
SIXI
Industrials
SIXI
Industrials
SIXI
+0,68%
1 730,38
+11,77
+0,68%
—1 718,611 723,231 741,481 717,47——
SIXM
Financials
SIXM
Financials
SIXM
+0,33%
639,47
+2,10
+0,33%
—637,37638,27642,30638,27——
SIXR
Staples
SIXR
Staples
SIXR
+0,16%
854,95
+1,36
+0,16%
—853,59854,05858,19851,34——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+0,11%
218,56
+0,23
+0,11%
—218,33218,33219,73217,15——
SIXT
Technology
SIXT
Technology
SIXT
+1,02%
3 631,59
+36,78
+1,02%
—3 594,813 620,103 657,473 615,34——
SIXU
Utilities
SIXU
Utilities
SIXU
+0,80%
915,77
+7,23
+0,80%
—908,54909,50917,35907,07——
SIXV
Health care
SIXV
Health care
SIXV
+1,19%
1 512,81
+17,81
+1,19%
—1 495,001 499,611 517,101 499,61——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0,41%
2 408,21
+9,90
+0,41%
—2 398,312 406,822 421,802 404,22——
DNA:NYSE
Ginkgo Bioworks Holdings Inc
8,41 US$
+4,08%
(+0,33) 1D
8,36 US$
-0,59% (-0,050)
After hours
Closed: 22 მაი, 16:00:03 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for DNA...
Open
8,18 US$
High
8,72 US$
Low
7,51 US$
Mkt. cap
524,15 მლნ.
Avg. vol.
1,25 მლნ.
Volume
875,32 ათ.
52-wk high
17,58 US$
52-wk low
5,37 US$
EPS
-5,35 US$
Beta
1,77
Shares outstanding
53,36 მლნ.
No. of employees
485
News stories
From sources across the web
Profile
Ginkgo Bioworks Holdings, Inc. is an American biotech company founded in 2008 by five scientists from MIT, headed by Jason Kelly. The company specializes in using genetic engineering to produce bacteria with industrial applications for other biotech companies, saving other companies the cost of reproducing the initial stages of design in synthetic biology. The self-proclaimed "Organism Company" was one of the world's largest privately held biotech companies, valued at $4.2 billion in 2019. It raised $290 million in September and $350 million in October of that year. Ginkgo Bioworks went public on the New York Stock Exchange via a SPAC merger on September 17, 2021. Wikipedia
About Ginkgo Bioworks Holdings Inc
CEOჯეისონ კელი
Employees485
Founded2008
Headquartersბოსტონი, მასაჩუსეტსი, ამერიკის შეერთებული შტატები
SectorHealth care
Websiteginkgo.bio
Last report
7 მაი. 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
-1,39 US$ / -
0,00%miss
Revenue / Est. (USD)
19,47 მლნ. / 42,96 მლნ.
-54,67%miss
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
ივნ. 2025
სექ. 2025
დეკ. 2025
მარ. 2026
Revenue
49,60 მლნ.
38,84 მლნ.
33,40 მლნ.
19,47 მლნ.
Cost of goods sold
14,82 მლნ.
12,80 მლნ.
7,30 მლნ.
3,10 მლნ.
Cost of revenue
14,82 მლნ.
12,80 მლნ.
7,30 მლნ.
3,10 მლნ.
Research and development expenses
53,37 მლნ.
69,35 მლნ.
50,13 მლნ.
49,92 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
43,28 მლნ.
44,95 მლნ.
46,01 მლნ.
37,83 მლნ.
Operating expense
96,65 მლნ.
114,31 მლნ.
96,14 მლნ.
87,75 მლნ.
Total operating expenses
111,47 მლნ.
127,11 მლნ.
103,44 მლნ.
90,85 მლნ.
Operating income
-61,87 მლნ.
-88,27 მლნ.
-70,05 მლნ.
-71,37 მლნ.
Other non operating income
-896,00 ათ.
-163,00 ათ.
821,00 ათ.
-388,00 ათ.
EBT including unusual items
-60,58 მლნ.
-80,75 მლნ.
-81,39 მლნ.
-76,14 მლნ.
EBT excluding unusual items
-56,68 მლნ.
-82,69 მლნ.
-62,01 მლნ.
-68,17 მლნ.
Income tax expense
-283,00 ათ.
1,00 ათ.
-643,00 ათ.
-80,00 ათ.
Effective tax rate
0,47%
-
0,79%
0,10%
Other operating expenses
-
-
-
-
Net income
-60,30 მლნ.
-80,76 მლნ.
-80,75 მლნ.
-82,59 მლნ.
Net profit margin
-121,56%
-207,93%
-241,80%
-424,09%
Earnings per share
-
-
-0,77
-
Interest and investment income
6,08 მლნ.
5,74 მლნ.
7,21 მლნ.
3,60 მლნ.
Interest expense
-
-
-
-
Net interest expenses
6,08 მლნ.
5,74 მლნ.
7,21 მლნ.
3,60 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
-41,37 მლნ.
-88,10 მლნ.
-61,08 მლნ.
-62,78 მლნ.
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer